BranchOut Food Inc

Aktienanalyse zu BranchOut Food Inc (BOF)

$3.960

-0.172 (-4.35%)Zum Schluss

Loading chart…
High
4.110
Open
4.110
VWAP
3.98
Vol
37.24K
Mkt Cap
2.90M
Low
3.860
Amount
148.10K
EV/EBITDA, TTM
-4.49

BranchOut Food Inc. is a growth-stage consumer packaged foods company. The Company is focused on developing, manufacturing, marketing, and distributing clean-label, plant-based dried fruit and vegetable snacks for retail and foodservice markets through BranchOut-branded products, private-label offerings, and industrial ingredient sales. It develops, manufactures, and markets dehydrated fruit and vegetable products using its GentleDry technology. Its products are primarily sold through three channels: branded retail snack products, private label products for major retailers, and fruit and vegetable ingredients sold to food manufacturers. Its segments include the United States Operations segment, which includes all sales, marketing, distribution, and customer relationships. Its Latin American Operations segment includes the Company's production and manufacturing activities, including its dehydration facility in Pisco, Peru, and related production support functions.

AI analysis of BranchOut Food Inc (BOF)

buy

BranchOut Food Inc. appears to be a good buy right now due to its recent revenue growth of 113% year-over-year and a current price of $3.96, which is significantly below the analyst price target of $6. The company has also secured a $1 million cash infusion to strengthen its balance sheet, indicating a proactive approach to financial health. However, the main risk is its negative net income of -$2,720,036 in Q2 2026, which reflects ongoing financial challenges.

Bewertungskennzahlen

The current forward P/E ratio for BranchOut Food Inc (BOF) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
Überbewertet
0.00
Unterbewertet
0.00

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
0.80
Current EV/EBITDA
-4.49
Überbewertet
10.92
Unterbewertet
-9.32

Forward P/S

Fair
5Y Average P/S
16.27
Current P/S
2.11
Überbewertet
200.83
Unterbewertet
-168.29

Alphio AI Price Scenarios for BOF

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%BOF

$2.85

Szenariopreis

B

Base

Base · 50%BOF

$2.49

Szenariopreis

B

Bear

Bear · 25%BOF

$2.43

Szenariopreis

Event-Zeitleiste

2026-08-27 (ET)

09:31:00

BranchOut Food Secures $750K Orders with Largest Warehouse Club

08:30:00

BranchOut Food Prices 820,588 Share Public Offering at $3.40 Each

2026-08-26 (ET)

17:30:00

BranchOut Food Commences Underwritten Public Offering of Common Stock

2026-07-21 (ET)

07:01:00

BranchOut Food Secures $2M Order from Second Largest Warehouse Club

2026-06-30 (ET)

19:00:00

BranchOut Food Secures $8M Sales Agreement with Warehouse Club

News

BOF FAQ — answered by Alphio AI

BranchOut Food Inc. is a growth-stage consumer packaged foods company. The Company is focused on developing, manufacturing, marketing, and distributing clean-label, plant-based dried fruit and vegetable snacks for retail and foodservice markets through BranchOut-branded products, private-label offerings, and industrial ingredient sales. It develops, manufactures, and markets dehydrated fruit and vegetable products using its GentleDry technology. Its products are primarily sold through three channels: branded retail snack products, private label products for major retailers, and fruit and vegetable ingredients sold to food manufacturers. Its segments include the United States Operations segment, which includes all sales, marketing, distribution, and customer relationships. Its Latin American Operations segment includes the Company's production and manufacturing activities, including its dehydration facility in Pisco, Peru, and related production support functions. It operates in the Consumer Non-Cyclicals sector (FOOD AND KINDRED PRODUCTS industry).

BranchOut Food Inc. appears to be a good buy right now due to its recent revenue growth of 113% year-over-year and a current price of $3.96, which is significantly below the analyst price target of $6. The company has also secured a $1 million cash infusion to strengthen its balance sheet, indicating a proactive approach to financial health. However, the main risk is its negative net income of -$2,720,036 in Q2 2026, which reflects ongoing financial challenges.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten